Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Eton Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +4 vs. Q2 2024
- Shares held
- 10.0M
- +1.56M (+18.5%) vs. Q2 2024
- Total value
- $60.0M
- +$32.2M (+116.1%) vs. Q2 2024
- New holders
- 13
- 11 more added
- Sold out
- 9
- 7 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,780,000 | $16.7M | 2.78% | +385,000+16.1% | Added |
| Vanguard Group Inc | 1,027,688 | $6.17M | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 998,733 | $5.99M | 0.50% | +58,000+6.2% | Added |
| Westside Investment Management, Inc. | 618,675 | $3.71M | 0.79% | +33,275+5.7% | Added |
| Acuitas Investments, LLC | 579,960 | $3.48M | 1.55% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 566,075 | $3.40M | 0.12% | +566,075 | New |
| National Philanthropic Trust | 492,112 | $2.95M | 0.05% | 00.0% | Unchanged |
| Paradigm Capital Management Inc | 300,000 | $1.80M | 0.08% | 00.0% | Unchanged |
| BlackRock, Inc. | 284,855 | $1.71M | 0.00% | +284,855 | New |
| Geode Capital Management, LLC | 272,696 | $1.64M | 0.00% | +32,365+13.5% | Added |
| Parkman Healthcare Partners LLC | 260,226 | $1.56M | 0.20% | +7,029+2.8% | Added |
| Bridgeway Capital Management, LLC | 253,362 | $1.52M | 0.03% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 238,565 | $1.43M | 0.01% | +238,565 | New |
| Aristides Capital LLC | 200,000 | $1.20M | 0.50% | 00.0% | Unchanged |
| EAM Investors, LLC | 128,276 | $769.7K | 0.12% | +128,276 | New |
| Susquehanna International Group, LLP | 119,347 | $716.1K | 0.00% | −14,941−11.1% | Reduced |
| Thompson Siegel & Walmsley LLC | 115,030 | $690.0K | 0.01% | −12,694−9.9% | Reduced |
| Acadian Asset Management LLC | 105,954 | $634.0K | 0.00% | −14,620−12.1% | Reduced |
| Renaissance Technologies LLC | 83,400 | $500.4K | 0.00% | −23,100−21.7% | Reduced |
| State Street Corp | 81,403 | $488.4K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 74,491 | $446.9K | 0.00% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 65,014 | $390.1K | 0.00% | +30,167+86.6% | Added |
| Northern Trust Corp | 64,130 | $384.8K | 0.00% | +4,281+7.2% | Added |
| Blair William & Co | 34,500 | $207.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 32,342 | $194.1K | 0.00% | +32,338+808,450.0% | Added |
| Essex Investment Management Co LLC | 27,252 | $163.5K | 0.03% | 00.0% | Unchanged |
| Citigroup Inc | 26,495 | $159.0K | 0.00% | +26,495 | New |
| Marshall Wace, LLP | 20,637 | $123.8K | 0.00% | +20,637 | New |
| UBS Group AG | 19,017 | $114.1K | 0.00% | +7,999+72.6% | Added |
| Schonfeld Strategic Advisors LLC | 17,200 | $103.2K | 0.00% | −33,717−66.2% | Reduced |
| Chicago Trust Co NA | 16,700 | $100.2K | 0.02% | 00.0% | Unchanged |
| Jane Street Group, LLC | 15,006 | $90.0K | 0.00% | +15,006 | New |
| Charles Schwab Investment Management Inc | 13,239 | $79.4K | 0.00% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 12,170 | $73.0K | 0.01% | +12,170 | New |
| Quantum Private Wealth, LLC | 11,500 | $69.0K | 0.02% | 00.0% | Unchanged |
| XTX Topco Ltd | 11,304 | $67.8K | 0.00% | −435−3.7% | Reduced |
| Raymond James & Associates | 10,250 | $61.5K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 8,927 | $53.6K | 0.01% | +8,927 | New |
| Cubist Systematic Strategies, LLC | 8,269 | $49.6K | 0.00% | +8,269 | New |
| Truvestments Capital LLC | 1,183 | $7.10K | 0.00% | +1,183 | New |
| Plante Moran Financial Advisors, LLC | 1,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 723 | $4.34K | 0.00% | +723 | New |
| Group One Trading, L.P. | 722 | $4.33K | 0.00% | +722 | New |
| Morgan Stanley | 472 | $2.83K | 0.00% | +280+145.8% | Added |
| BNP Paribas Arbitrage, SA | 350 | $2.10K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 275 | $2.00K | 0.00% | −472−63.2% | Reduced |
| Advisor Group Holdings, Inc. | 300 | $1.80K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 201 | $1.21K | 0.00% | +18+9.8% | Added |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −57,503−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −41,255−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,485−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −10,564−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,638−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |